Vera Therapeutics Inc (VERA)
Healthcare
Biotechnology
32.10 $
-2.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Vera Therapeutics Inc (VERA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -107 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -18 | -23 | -25 | -34 | -25 | -37 | -39 | -54 | -55 | -62 | -70 | -107 | -293 | |
| 0.5 | 0.0 | -0.6 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.6 | |
| 2.7 | 2.9 | 3.2 | 4.1 | 4.9 | 5.6 | 6.2 | 7.7 | 9.5 | 9.7 | 11 | 13 | 43 | |
| 3.3 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.1 | -4.9 | -2.1 | -8.6 | 6.1 | 5.9 | -0.7 | -9.4 | 13 | 8.7 | 10 | -14 | 19 | |
| 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 25 | 0.6 | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.6 | |
| -86 | 16 | 19 | -219 | -23 | 38 | -221 | 15 | 29 | 70 | 81 | -138 | 41 | |
| – | – | – | – | – | 0.0 | 0.0 | – | – | – | 0.0 | – | – | |
| – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | – | – | |
| 0.4 | 0.3 | 25 | 277 | 3.4 | 0.7 | 326 | 1.5 | 20 | 0.8 | 286 | 3.9 | 311 | |
| -104 | -6.4 | 18 | 23 | -44 | 2.2 | 65 | -38 | -6.0 | 8.7 | 297 | -240 | 59 | |
| -18 | -23 | -25 | -34 | -25 | -62 | -40 | -55 | -55 | -62 | -70 | -107 | -294 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.